159 related articles for article (PubMed ID: 16518958)
1. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.
Balan V; Nelson DR; Sulkowski MS; Everson GT; Lambiase LR; Wiesner RH; Dickson RC; Post AB; Redfield RR; Davis GL; Neumann AU; Osborn BL; Freimuth WW; Subramanian GM
Antivir Ther; 2006; 11(1):35-45. PubMed ID: 16518958
[TBL] [Abstract][Full Text] [Related]
2. Alpha-interferon (IFN-alpha) treatment of chronic hepatitis C: analysis of some predictive factors for the response.
Malaguarnera M; Di Fazio I; Trovato BA; Pistone G; Mazzoleni G
Int J Clin Pharmacol Ther; 2001 Jun; 39(6):239-45. PubMed ID: 11430631
[TBL] [Abstract][Full Text] [Related]
3. Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions.
Khakoo S; Glue P; Grellier L; Wells B; Bell A; Dash C; Murray-Lyon I; Lypnyj D; Flannery B; Walters K; Dusheiko GM
Br J Clin Pharmacol; 1998 Dec; 46(6):563-70. PubMed ID: 9862245
[TBL] [Abstract][Full Text] [Related]
4. Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group.
Glue P; Fang JW; Rouzier-Panis R; Raffanel C; Sabo R; Gupta SK; Salfi M; Jacobs S
Clin Pharmacol Ther; 2000 Nov; 68(5):556-67. PubMed ID: 11103758
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys.
Osborn BL; Olsen HS; Nardelli B; Murray JH; Zhou JX; Garcia A; Moody G; Zaritskaya LS; Sung C
J Pharmacol Exp Ther; 2002 Nov; 303(2):540-8. PubMed ID: 12388634
[TBL] [Abstract][Full Text] [Related]
6. [Seizures during the treatment with interferon for chronic C hepatitis].
Anton C; Trifan A; Stanciu C; Stanciu GO; Malgarinos G
Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):135-7. PubMed ID: 12089978
[TBL] [Abstract][Full Text] [Related]
7. Side effects of alpha interferon in chronic hepatitis C.
Dusheiko G
Hepatology; 1997 Sep; 26(3 Suppl 1):112S-121S. PubMed ID: 9305675
[TBL] [Abstract][Full Text] [Related]
8. [Complete cytogenetic response to interferon-alpha in a patient with chronic myelogenous leukemia undergoing hemodialysis].
Doi S; Edamura S; Akasaka H; Kawamura M; Arima N; Nasu K
Rinsho Ketsueki; 2001 Jul; 42(7):549-53. PubMed ID: 11524845
[TBL] [Abstract][Full Text] [Related]
9. Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C.
Fujii H; Kitada T; Yamada T; Sakaguchi H; Seki S; Hino M
Hepatogastroenterology; 2003; 50(51):841-2. PubMed ID: 12828100
[TBL] [Abstract][Full Text] [Related]
10. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
[TBL] [Abstract][Full Text] [Related]
11. Interferon-induced anosmia in a patient with chronic hepatitis C.
Maruyama S; Hirayama C; Kadowaki Y; Sagayama A; Omura H; Nakamoto M
Am J Gastroenterol; 1998 Jan; 93(1):122-3. PubMed ID: 9448193
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of alpha2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): a trial of the Eastern Cooperative Oncology Group.
Radin AI; Kim HT; Grant BW; Bennett JM; Kirkwood JM; Stewart JA; Hahn RG; Dutcher JP; Wiernik PH; Oken MM;
Cancer; 2003 Jul; 98(1):100-9. PubMed ID: 12833462
[TBL] [Abstract][Full Text] [Related]
13. [Chronic hepatitis C in a 12-year-old girl coinfected with HGV].
Szaflarska-Szczepanik A; Loś E; Krenska-Wiacek A; Chrobot A
Pol Merkur Lekarski; 1999 Jul; 7(37):21-2. PubMed ID: 10522407
[TBL] [Abstract][Full Text] [Related]
14. Host factors and failure of interferon-alpha treatment in hepatitis C virus.
Gao B; Hong F; Radaeva S
Hepatology; 2004 Apr; 39(4):880-90. PubMed ID: 15057887
[TBL] [Abstract][Full Text] [Related]
15. [Interferon therapy in hepatitis C].
Ferenci P
Wien Med Wochenschr; 1993; 143(16-17):461-4. PubMed ID: 8273373
[TBL] [Abstract][Full Text] [Related]
16. [Interferon-alpha. Results of a pharmaco-epidemiologic study].
Grion AM; Gaion RM; Cordella L; Bano F; Cannada RA; Innamorati G; Berti T
Clin Ter; 1994 Mar; 144(3):201-11. PubMed ID: 8181216
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study of human natural beta-interferon in patients with end-stage renal failure.
Nakayama H; Shiotani S; Akiyama S; Gotoh H; Tani M; Akine Y
Clin Nephrol; 2001 Nov; 56(5):382-6. PubMed ID: 11758009
[TBL] [Abstract][Full Text] [Related]
18. [Alpha interferon-induced eczema in atopic patients infected by hepatitis C virus: 4 case reports].
Berger L; Descamps V; Marck Y; Dehen L; Grossin M; Crickx B; Marcellin P; Belaich S
Ann Dermatol Venereol; 2000 Jan; 127(1):51-5. PubMed ID: 10717563
[TBL] [Abstract][Full Text] [Related]
19. [Depressive disorders and interferon alpha].
Hardy P
Gastroenterol Clin Biol; 1996; 20(3):255-7. PubMed ID: 8763063
[No Abstract] [Full Text] [Related]
20. Changes of antipyrine pharmacokinetics during influenza and after administration of interferon-alpha and -beta.
Brockmeyer NH; Barthel B; Mertins L; Goos M
Int J Clin Pharmacol Ther; 1998 Jun; 36(6):309-11. PubMed ID: 9660037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
